Home > Worldwide > Takeda Pharmaceuticals North America, Inc.
Main contents starts here
Takeda Pharmaceuticals North America, Inc.
| Home page | |
|---|---|
| Business | Marketing |
| Key Products | (pioglitazone hydrochloride) |
| (ramelteon) | |
| (lubiprostone)* | |
| *Amitiza is a trademark of Sucampo Pharmaceuticals, Inc. | |
| Address | One Takeda Parkway, Deerfield, IL 60015, USA |
| Telephone | +1-224-554-6500 |
| Contact | |
| Founded | 1998 |
Takeda Pharmaceuticals North America, Inc. (TPNA) is a wholly owned subsidiary of Takeda Pharmaceutical Company Limited.
In the United States, TPNA currently markets oral diabetes, sleep, gastroenterology and cholesterol lowering treatments, and through the Takeda Global Research & Development Center, Inc. the company has a robust pipeline with compounds in development for diabetes, cardiovascular disease and other conditions.
[*]The information presented at each company's website is governed by laws and regulations of that particular country, and therefore is intended for residents in that country only.
